These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38954737)

  • 21. Dual Competing Photovoltaic Supply Chains: A Social Welfare Maximization Perspective.
    Chen Z; Su SI
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29156653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical enterprises drug quality strategy
    Xu Y; Zhu L
    Front Public Health; 2022; 10():1079232. PubMed ID: 36733287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the Interaction Effect between the Intensity of Government Low-Carbon Subsidies and the Growth Ability of Green and Low-Carbon Emerging Enterprises.
    Chen L; Huang J
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stockpile Model of Personal Protective Equipment in Taiwan.
    Chen YJ; Chiang PJ; Cheng YH; Huang CW; Kao HY; Chang CK; Huang HM; Liu PY; Wang JH; Chih YC; Chou SM; Yang CH; Chen CH
    Health Secur; 2017; 15(2):170-174. PubMed ID: 28418743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers.
    Atif M; Malik I; Mushtaq I; Asghar S
    BMJ Open; 2019 Sep; 9(9):e027028. PubMed ID: 31488466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital Transformation on Enterprise Green Innovation: Effect and Transmission Mechanism.
    Feng H; Wang F; Song G; Liu L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Government environmental protection subsidies, environmental tax collection, and green innovation: evidence from listed enterprises in China.
    Jiang Z; Xu C; Zhou J
    Environ Sci Pollut Res Int; 2023 Jan; 30(2):4627-4641. PubMed ID: 35971054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy.
    Khan MAA; Rauf A
    J Pharm Policy Pract; 2024; 17(1):2323683. PubMed ID: 38444526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do Chinese enterprises make imitative innovation?-An empirical explanation based on government subsidies.
    Song F; Zhao C
    Front Psychol; 2022; 13():802703. PubMed ID: 36172242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A game theory data science-based mechanism for licensed pharmaceutical products concerning their deterioration: a case of a micro, small, and medium enterprise in Iran.
    Mostofi A; Jain V; Kumar S; Mei Y; Chandra C
    Ann Oper Res; 2023 May; ():1-35. PubMed ID: 37361076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary game analysis of air pollution co-investment in emission reductions by steel enterprises under carbon quota trading mechanism.
    Zhang C; Zhang X
    J Environ Manage; 2022 Sep; 317():115376. PubMed ID: 35642823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-evolutionary simulation study of multiple stakeholders in the take-out waste recycling industry chain.
    Long R; Yang J; Chen H; Li Q; Fang W; Wang L
    J Environ Manage; 2019 Feb; 231():701-713. PubMed ID: 30396143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A remanufacturing supply chain network with differentiated new and remanufactured products considering consumer preference, production capacity constraint and government regulation.
    Zhang X; Zhou G; Cao J; Lu J
    PLoS One; 2023; 18(8):e0289349. PubMed ID: 37561709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical Enterprises' R&D Innovation Cooperation Moran Strategy When Considering Tax Incentives.
    Xu Y; Zhu L
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Drug Shortage Era: A Scoping Review of the Literature 2001-2019.
    Tucker EL; Cao Y; Fox ER; Sweet BV
    Clin Pharmacol Ther; 2020 Dec; 108(6):1150-1155. PubMed ID: 32521038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research on green decision making of pharmaceutical logistics considering government subsidy strategy.
    Huang Z; Fu M
    PLoS One; 2020; 15(10):e0241400. PubMed ID: 33125413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. API Global Sourcing Strategies 2010.
    Bennett S
    IDrugs; 2010 Sep; 13(9):605-6. PubMed ID: 20799139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Driving Mechanism Model for the Supply Chain Work Safety Management Behavior of Core Enterprises-An Exploratory Research Based on Grounded Theory.
    Zhou Q; Mei Q; Liu S; Zhang J; Wang Q
    Front Psychol; 2021; 12():807370. PubMed ID: 35185703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A game theoretical model for the stimulation of public cooperation in environmental collaborative governance.
    Fang Y; Perc M; Zhang H
    R Soc Open Sci; 2022 Nov; 9(11):221148. PubMed ID: 36405643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environmental Compliance and Enterprise Innovation: Empirical Evidence from Chinese Manufacturing Enterprises.
    Liu M; Liu Y; Zhao Y
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.